{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Sodium_Dichloroacetate",
  "nciThesaurus": {
    "casRegistry": "2156-56-1",
    "chebiId": "",
    "chemicalFormula": "C2HCl2O2.Na",
    "definition": "The sodium salt of dichloroacetic acid with potential antineoplastic activity. Dichloroacetate ion inhibits pyruvate dehydrogenase kinase, resulting in the inhibition of glycolysis and a decrease in lactate production. This agent may stimulate apoptosis in cancer cells by restoring normal mitochondrial-induced apoptotic signaling.",
    "fdaUniiCode": "42932X67B5",
    "identifier": "C73591",
    "preferredName": "Sodium Dichloroacetate",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C129839",
      "C471"
    ],
    "synonyms": [
      "CPC 211",
      "Dichloroacetic Acid, Sodium Salt",
      "SODIUM DICHLOROACETATE",
      "Sodium Dichloroacetate"
    ]
  }
}